BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27604355)

  • 1. Cell Proliferation and Cytotoxicity Assays.
    Adan A; Kiraz Y; Baran Y
    Curr Pharm Biotechnol; 2016; 17(14):1213-1221. PubMed ID: 27604355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell viability and cytotoxicity assays: Biochemical elements and cellular compartments.
    Khalef L; Lydia R; Filicia K; Moussa B
    Cell Biochem Funct; 2024 Apr; 42(3):e4007. PubMed ID: 38593323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2.
    Nowak E; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2018; 69(1-2):327-336. PubMed ID: 29630545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-content image analysis (HCIA) assay has the highest correlation with direct counting cell suspension compared to the ATP, WST-8 and Alamar blue assays for measurement of cytotoxicity.
    Tahara H; Matsuda S; Yamamoto Y; Yoshizawa H; Fujita M; Katsuoka Y; Kasahara T
    J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):92-99. PubMed ID: 28807796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytotoxicity assay utilizing a fluorescent dye that determines accurate surviving fractions of cells.
    Sellers JR; Cook S; Goldmacher VS
    J Immunol Methods; 1994 Jun; 172(2):255-64. PubMed ID: 8034974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay.
    Elia MC; Storer RD; Harmon LS; Kraynak AR; McKelvey TW; Hertzog PR; Keenan KP; DeLuca JG; Nichols WW
    Mutat Res; 1993 Jun; 291(3):193-205. PubMed ID: 7685060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity Assays as Predictors of the Safety and Efficacy of Antimicrobial Agents.
    Zipperer A; Kretschmer D
    Methods Mol Biol; 2017; 1520():107-118. PubMed ID: 27873248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell viability assays: introduction.
    Stoddart MJ
    Methods Mol Biol; 2011; 740():1-6. PubMed ID: 21468961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations.
    Altman SA; Randers L; Rao G
    Biotechnol Prog; 1993; 9(6):671-4. PubMed ID: 7764357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles.
    Braun K; Stürzel CM; Biskupek J; Kaiser U; Kirchhoff F; Lindén M
    Toxicol In Vitro; 2018 Oct; 52():214-221. PubMed ID: 29940343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular chemosensitivity assays: an overview.
    Sumantran VN
    Methods Mol Biol; 2011; 731():219-36. PubMed ID: 21516411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameters for evaluation of viability assays: accuracy, precision, specificity, sensitivity, and standardization.
    Bank HL; Schmehl MK
    Cryobiology; 1989 Jun; 26(3):203-11. PubMed ID: 2743784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Cytotoxicity.
    Prog Drug Res; 2016; 71():159-61. PubMed ID: 26939283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity.
    Weisenthal LM; Dill PL; Kurnick NB; Lippman ME
    Cancer Res; 1983 Jan; 43(1):258-64. PubMed ID: 6571706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of uptake, cytotoxicity and inflammatory effects in respiratory cells exposed to pristine and -OH and -COOH functionalized multi-wall carbon nanotubes.
    Ursini CL; Maiello R; Ciervo A; Fresegna AM; Buresti G; Superti F; Marchetti M; Iavicoli S; Cavallo D
    J Appl Toxicol; 2016 Mar; 36(3):394-403. PubMed ID: 26370214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro methods for detecting cytotoxicity.
    Ehrich M; Sharova L
    Curr Protoc Toxicol; 2001 May; Chapter 2():Unit 2.6. PubMed ID: 23045046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tumor and endothelial cell viability and survival using sulforhodamine B and clonogenic assays.
    Woolston C; Martin S
    Methods Mol Biol; 2011; 740():45-56. PubMed ID: 21468967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and computational approach to establish fit-for-purpose cell viability assays.
    Pierce L; Anderson H; Sarkar S; Bauer SR; Sarkar S
    Regen Med; 2024 Jan; 19(1):27-45. PubMed ID: 38247346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of the fluorescent probe viability assay.
    Massaro EJ; Elstein KH; Zucker RM; Bair KW
    Mol Toxicol; 1989; 2(4):271-84. PubMed ID: 2490980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honey is cytotoxic towards prostate cancer cells but interacts with the MTT reagent: Considerations for the choice of cell viability assay.
    Abel SDA; Baird SK
    Food Chem; 2018 Feb; 241():70-78. PubMed ID: 28958561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.